Thrombophilia is a health condition characterized by an increased risk of thromboembolism, which refers to the formation of blood clots that block blood vessels. These clots can lead to serious health problems, such as stroke, pulmonary embolism, and deep vein thrombosis. Thrombophilia can be caused by various factors, including genetic mutations, acquired conditions, and environmental factors.
Clinical Significance of Thrombophilia
It is estimated that approximately 1% of the general population may have a genetic predisposition to thrombophilia.
Some genetic mutations that increase the risk of thrombophilia include Factor V Leiden, Prothrombin G20210A, and MTHFR mutations.
These mutations can lead to the formation of abnormal blood clots, which can cause a range of health problems. For example, individuals with thrombophilia may have an increased risk of developing deep vein thrombosis, which occurs when a blood clot forms in the deep veins of the legs, arms, or pelvis. Deep vein thrombosis can lead to severe complications such as pulmonary embolism, which can be fatal if left untreated.
Negative Effects of Thrombophilia on Pregnancy
Pregnant women with thrombophilia have an increased risk of developing complications such as preeclampsia, intrauterine growth restriction, and stillbirth. These complications are believed to occur due to the increased risk of blood clotting during pregnancy. Additionally, thrombophilia can increase the risk of pregnancy loss and recurrent miscarriage.
In vitro fertilization (IVF) is a type of reproductive technology used to help couples struggling with infertility. IVF involves fertilizing an egg outside the body and subsequent transfer of the embryo into the uterus. IVF can be challenging for individuals with thrombophilia because the hormonal stimulation used during IVF can increase the risk of blood clotting. Additionally, pregnancy itself increases the risk of clotting, so individuals with thrombophilia who undergo IVF may be at even greater risk of developing complications.
Real-time PCR – The Most Effective Method for Detecting Thrombophilia-related Mutations
Real-time PCR tests are the most effective for detecting and identifying mutations associated with thrombophilia. PCR (polymerase chain reaction) is a laboratory technique used for DNA sequence amplification.
PCR testing can be used to identify mutations in genes such as Factor V Leiden, Prothrombin G20210A, and MTHFR. These genetic mutations can increase the risk of thrombophilia, while PCR testing can help identify individuals who may be at higher risk of developing thrombophilia. This information can be used to help treat and prevent complications associated with thrombophilia.
Our comprehensive thrombophilia panel analyzes up to 12 genes associated with increased risk of thrombophilia.
Thrombophilia is a health condition characterized by an increased risk of thromboembolism, which refers to the formation of blood clots that block blood vessels. These clots can lead to serious health problems, such as stroke, pulmonary embolism, and deep vein thrombosis. Thrombophilia can be caused by various factors, including genetic mutations, acquired conditions, and environmental factors.
The clinical significance of thrombophilia is very high. It is estimated that approximately 1% of the general population may have a genetic predisposition to thrombophilia. Some genetic mutations that increase the risk of thrombophilia include Factor V Leiden, Prothrombin G20210A, and MTHFR mutations.
These mutations can lead to the formation of abnormal blood clots, which can cause a range of health problems. For example, individuals with thrombophilia may have an increased risk of developing deep vein thrombosis, which occurs when a blood clot forms in the deep veins of the legs, arms, or pelvis. Deep vein thrombosis can lead to severe complications such as pulmonary embolism, which can be fatal if left untreated.
Thrombophilia can also have negative consequences on pregnancy. Pregnant women with thrombophilia have an increased risk of developing complications such as preeclampsia, intrauterine growth restriction, and stillbirth. These complications are believed to occur due to the increased risk of blood clotting during pregnancy. Additionally, thrombophilia can increase the risk of pregnancy loss and recurrent miscarriage.
In vitro fertilization (IVF) is a type of reproductive technology used to help couples struggling with infertility. IVF involves fertilizing an egg outside the body and subsequent transfer of the embryo into the uterus. IVF can be challenging for individuals with thrombophilia because the hormonal stimulation used during IVF can increase the risk of blood clotting. Additionally, pregnancy itself increases the risk of clotting, so individuals with thrombophilia who undergo IVF may be at even greater risk of developing complications.
Real-time PCR tests are the most effective for detecting and identifying mutations associated with thrombophilia. PCR (polymerase chain reaction) is a laboratory technique used for DNA sequence amplification.
PCR testing can be used to identify mutations in genes such as Factor V Leiden, Prothrombin G20210A, and MTHFR. These genetic mutations can increase the risk of thrombophilia, while PCR testing can help identify individuals who may be at higher risk of developing thrombophilia. This information can be used to help treat and prevent complications associated with an increased risk of thrombophilia.
Panels
Our comprehensive thrombofolate panel analyzes as many as 12 genes associated with an increased risk of thrombophilia.
Of these, 8 genes are directly related to the hemostasis process: F2 20210 G>A, F5 1691 A, F7 10976 G>A, F13 Val34Leu, FGB -455 G>A, ITGA2 807 C>T, ITGB3 1565 T>C, PAI-1 -675 4G>5G; and 4 genes are indirectly related to thrombophilia through folate metabolism: MTHFR 677 C>T, MTHFR 1298 A>C, MTR 2756 A>G, and MTRR 66 A>G.
